The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

By E. Campo, S. Swerdlow, N. Harris, S. Pileri, H. Stein, Elaine S. Jaffe. Blood, 2011

2,111 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/4267430e80c2810c688677d85d6e2c9284400eb5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. J. Fishman

In Oncology

1. J. Fishman

In Pathology and Forensic Medicine

1. J. Fishman

Citations in the corpus

• The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (2016, background): “Segregation of these cases was also necessary to better define these clinically problematic tumors.(3) Additional studies followed that demonstrated that BCLU and other LBCL, with rearrangements of MYC and BCL2 and/or BCL6, had mutational features intermediate between DLBCL and BL.”
• Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network (2011, background): “…that the rapid rate of progress in understanding tumour biology, and the introduction of new diagnostic technologies and treatments mean WHO classifications, will inevitably require ongoing revision (World Health Organization, 2001; WHO, 2008; Jaffe, 2009; Vardiman et al, 2009; Campo et al, 2011).”